Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1991 1
1992 3
1993 1
1994 3
1995 1
1996 4
1997 4
2001 2
2005 2
2006 1
2008 1
2009 6
2010 2
2011 1
2013 1
2015 1
2020 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
Wykoff CC, Brown DM, Reed K, Berliner AJ, Gerstenblith AT, Breazna A, Abraham P, Fein JG, Chu KW, Clark WL, Leal S, Schmelter T, Hirshberg B, Yancopoulos GD, Vitti R; CANDELA Study Investigators. Wykoff CC, et al. JAMA Ophthalmol. 2023 Sep 1;141(9):834-842. doi: 10.1001/jamaophthalmol.2023.2421. JAMA Ophthalmol. 2023. PMID: 37535382
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Brown DM, Boyer DS, Do DV, Wykoff CC, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Rao R, Cheng Y, Sun W, Voronca D, Bhore R, Schmidt-Ott U, Schmelter T, Schulze A, Zhang X, Hirshberg B, Yancopoulos GD, Sivaprasad S; PHOTON Investigators. Brown DM, et al. Lancet. 2024 Mar 23;403(10432):1153-1163. doi: 10.1016/S0140-6736(23)02577-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461843 Clinical Trial.
Diabetic retinopathy and angiogenesis.
Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP. Crawford TN, et al. Among authors: alfaro dv 3rd. Curr Diabetes Rev. 2009 Feb;5(1):8-13. doi: 10.2174/157339909787314149. Curr Diabetes Rev. 2009. PMID: 19199892 Review.
Anti-macular degeneration agents.
Rothen M, Jablon E, Monares G, Fontal MR, Alfaro DV 3rd. Rothen M, et al. Among authors: alfaro dv 3rd. Ophthalmol Clin North Am. 2005 Dec;18(4):561-7. doi: 10.1016/j.ohc.2005.07.009. Ophthalmol Clin North Am. 2005. PMID: 16314219 Review.
Paediatric post-traumatic endophthalmitis.
Alfaro DV, Roth DB, Laughlin RM, Goyal M, Liggett PE. Alfaro DV, et al. Br J Ophthalmol. 1995 Oct;79(10):888-91. doi: 10.1136/bjo.79.10.888. Br J Ophthalmol. 1995. PMID: 7488575 Free PMC article. Review.
Metabolic control and diabetic retinopathy.
Rodriguez-Fontal M, Kerrison JB, Alfaro DV, Jablon EP. Rodriguez-Fontal M, et al. Among authors: alfaro dv. Curr Diabetes Rev. 2009 Feb;5(1):3-7. doi: 10.2174/157339909787314176. Curr Diabetes Rev. 2009. PMID: 19199891 Review.
Intravitreal triamcinolone for the treatment of diabetic macular edema.
Gómez-Ulla F, Marticorena J, Alfaro DV 3rd, Fernández M, Méndez ER, Rothen M. Gómez-Ulla F, et al. Among authors: alfaro dv 3rd. Curr Diabetes Rev. 2006 Feb;2(1):99-112. doi: 10.2174/157339906775473572. Curr Diabetes Rev. 2006. PMID: 18220620 Review.
Fishing-related ocular trauma.
Alfaro DV 3rd, Jablon EP, Rodriguez Fontal M, Villalba SJ, Morris RE, Grossman M, Roig-Melo E. Alfaro DV 3rd, et al. Am J Ophthalmol. 2005 Mar;139(3):488-92. doi: 10.1016/j.ajo.2004.10.011. Am J Ophthalmol. 2005. PMID: 15767058
42 results